MCL1 and cancer: Thousands of mRNAs are ELAVL1 targets, including factors fostering diverse cancer traits such as proliferation (cyclins A2, B1, D1, and E1), angiogenesis (HIF1a, PTGS2, and VEGFA), survival (BCL2 and MCL1), and invasion (MMP9 and SNAI1) [59,60].